Meditation as a bioactive intervention: evidence of translational potential via Connectivity Mapping and TMS neurophysiology
Frontiers in Human Neuroscience · 09.11.2026 · 20
DOI: 10.3389/fnhum.2026.1904068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Human Neuroscience, online erschienen am 09.11.2026. Verfasst von Aditi Joshi und 3 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Meditation practices are often used as non-pharmacological adjunct therapy for managing stress and wellbeing benefits. Here, we investigate whether molecular signatures via meditation practices have potential overlap with those of known drug targets that have established neurophysiological relevance.
Method
We leverage the Connectivity Map (CMap) to investigate (a) the overlap between meditation-induced molecular signatures and established drug responses, and (b) the pathways and mechanisms contributing to meditation’s potential therapeutic effects. This was studied in a comprehensive temporal RNAseq dataset comprising premeditation, meditation, and follow-up stages from a clinical trial involving 106 participants practizing inner engineering meditation. With Multiple Correspondence Analysis (MCA), we then examined how overlapping neuroactive drug classes identified from a systematic-literature search derived pharmaco-Transcranial Magnetic Stimulation (TMS) responses and CMap results co-occurred within a shared latent space.
Results
Meditation associated signatures overlapped with over 438 drugs, but predominantly with drugs targeting the neuroactive ligand interaction receptor pathways, capable of modulating the brain’s excitation-inhibition (E/I) balance. We found that meditation associated transcriptome signatures showed connectivity with drugs targeting the GABA, glutamine and other neuromodulatory system pathways. This pattern was further corroborated by Multiple Correspondence Analysis (MCA) of drugs from pharmaco-TMS studies and CMap, which revealed distinct temporal patterns of these drug classes across meditation stages.
Conclusion
This integrative approach offers a molecular lens to view meditation’s potential neurophysiological effects. Rather than establishing causal mechanisms, our findings are intended to generate hypotheses: how meditation-associated molecular pathway changes might relate to shifts in E/I balance. We propose a working model to test these associations directly using neurophysiological measures, with the eventual goal of informing evidence-based clinical applications. Overall, these exploratory findings have increased the potential possibility to correlate meditation with biologically relevant molecular and neurophysiological correlates, hence, providing an additional dimension to meditation’s currently established characterization as a psychological and contemplative practice.
Zitieren
APA
Joshi, A., Muralidharan, V., Patel, D., & Mukerji, M. (2026). Meditation as a bioactive intervention: evidence of translational potential via Connectivity Mapping and TMS neurophysiology. Frontiers in Human Neuroscience, 20. https://doi.org/10.3389/fnhum.2026.1904068
Vancouver
Joshi A, Muralidharan V, Patel D, Mukerji M. Meditation as a bioactive intervention: evidence of translational potential via Connectivity Mapping and TMS neurophysiology. Frontiers in Human Neuroscience. 2026;20. doi:10.3389/fnhum.2026.1904068
BibTeX
@article{Joshi2026,
author = {Joshi, Aditi and Muralidharan, Vignesh and Patel, Deep and Mukerji, Mitali},
title = {Meditation as a bioactive intervention: evidence of translational potential via Connectivity Mapping and TMS neurophysiology},
journal = {Frontiers in Human Neuroscience},
year = {2026},
volume = {20},
doi = {10.3389/fnhum.2026.1904068}
}
EUVIMED